United States / USD Country & Currency
Country
United States
Currency
US Dollars
Save
Country
Australia
Bahrain
Barbados
Belgium
Cayman Islands
Cyprus
Falkland Islands
Gibraltar
Grenada
Guam
Hong Kong
India
Latvia
Malaysia
Maldives
Malta
Martinique
Monaco
Montserrat
Namibia
Netherlands
Northern Ireland
Poland
Puerto Rico
Scotland
Singapore
St Lucia
St Vincent and the Grenadines
Sweden
Switzerland
Taiwan
Thailand
United Kingdom
United States
Currency
US Dollars
GB Pounds
AU Dollars
Euro
Explore our range Categories
Ask us a question 877-271-6591 or 800-868-9064

Shipping delays due to Covid-19 Virus

Please fill the form to receive updates when we can ship your order.

Jardiance (Empagliflozin 25mg) 30 Tablets/Pack


Jardiance (Empagliflozin 25mg) 30 Tablets/Pack

Jardiance (Empagliflozin 25mg)


Product Name
Jardiance (Empagliflozin 25mg) 30 Tablets/Pack
Original branded product made in Germany for the Turkish market - comes with English language leaflet.
Active Ingredient
Empagliflozin
Manufacturer
Boehringer Ingelheim
Product Type
Antihyperglycaemic
Product expiry date we are currently shipping
Currently out of stock. New stock expected 27 May 2021.

Jardiance tablets contain the antihyperglycaemic medication, empagliflozin 25mg to assist type-2 diabetics in maintaining control over their blood glucose levels.

Product Price List
REMEMBER SHIPPING IS FREE!

Jardiance (Empagliflozin) 25mg 30 Tablets
$2.60 per Tablet
|
$78.00 (USD) 
$78.00 (USD) 
Out of stock
Jardiance (Empagliflozin) 25mg 60 Tablets
$2.40 per Tablet
|
$144.00 (USD) 
$144.00 (USD) 
Out of stock
Jardiance (Empagliflozin) 25mg 90 Tablets
$2.20 per Tablet
|
$198.00 (USD) 
$198.00 (USD) 
Out of stock
Let us notify you when this product is back in stock
Unfortunately, Jardiance (Empagliflozin 25mg) is currently out of stock. Please enter your email address below and we will notify you when more stock becomes available.
Your email address:

Jardiance tablets contain the antihyperglycaemic medication, empagliflozin 25mg to improve control over blood sugar levels.

Type-2 diabetes is associated with increased risk of cardiovascular disease, blindness, kidney failure and stroke. The addition of Januvia to a diabetes management plan of dietary improvements and regular exercise helps to improve the health outcomes for diabetics who have a shorter life expectancy.

Empagliflozin belongs to the gliflozin group of medications that work by inhibiting the reabsorption of glucose by the kidney. Blood glucose levels are reduced and there is increased glucose excretion in the urine. Often there is a reduction in body weight and reduced blood pressure because of the actions of empagliflozin resulting in improved blood glucose control.

Other products in
Diabetes
 

This website uses cookies. View our policy and select your preferences here